TSE:APHAAphria Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aphria Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$5.81 -0.05 (-0.85 %) (As of 07/10/2020 06:00 AM ET) Add Compare Share Today's RangeC$5.75Now: C$5.81▼C$5.9050-Day RangeC$4.91MA: C$5.86▼C$6.7852-Week RangeC$2.65Now: C$5.81▼C$10.05Volume989,142 shsAverage Volume3.50 million shsMarket CapitalizationC$1.55 billionP/E Ratio50.09Dividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsHeadlinesOptions ChainSocial Media Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.Read More Beat the Market (BTM) Rank™ 3.4 Analyst's Opinion Consensus RatingAphria has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$7.73, Aphria has a potential upside of 33.0% from its current price of C$5.81.Amount of Analyst CoverageAphria has only been the subject of 2 research reports in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesAphria has received 372 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAphria has received 333 “underperform” votes. (Add your “underperform” vote.)Community SentimentAphria has received 52.77% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote “Outperform” if you believe APHA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAphria does not currently pay a dividend.Dividend GrowthAphria does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aphria insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Aphria are expected to grow in the coming year, from C($0.02) to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aphria is 50.09, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.02.Price to Earnings Ratio vs. SectorThe P/E ratio of Aphria is 50.09, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.97.Price to Book Value per Share RatioAphria has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.45 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:APHA Previous Symbol CUSIPN/A CIKN/A Webwww.aphria.com Phone844-427-4742Debt Debt-to-Equity Ratio26.02 Current Ratio5.19 Quick Ratio3.37Price-To-Earnings Trailing P/E Ratio50.09 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$518.70 million Price / Sales3.00 Cash FlowC$1.92 per share Price / Cash Flow3.02 Book ValueC$6.88 per share Price / Book0.84Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees300 Outstanding Shares267,587,008Market CapC$1.55 billion Next Earnings Date7/30/2020 (Estimated) OptionableOptionable TSX:APHA Rates by TradingView Receive APHA News and Ratings via Email Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter. Aphria (TSE:APHA) Frequently Asked Questions How has Aphria's stock been impacted by COVID-19 (Coronavirus)? Aphria's stock was trading at C$3.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, APHA shares have increased by 57.9% and is now trading at C$5.81. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Aphria? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aphria. When is Aphria's next earnings date? Aphria is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Aphria. What price target have analysts set for APHA? 5 brokers have issued 12-month price objectives for Aphria's stock. Their forecasts range from C$5.30 to C$11.00. On average, they anticipate Aphria's stock price to reach C$7.73 in the next twelve months. This suggests a possible upside of 33.0% from the stock's current price. View analysts' price targets for Aphria. Has Aphria been receiving favorable news coverage? Media stories about APHA stock have trended negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aphria earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Aphria. Who are some of Aphria's key competitors? Some companies that are related to Aphria include Hikma Pharmaceuticals (HIK), Evotec (EVT), Aurora Cannabis (ACB), Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), Hexo (HEXO), OrganiGram (OGI), HEXO (HEXO), Amryt Pharma (AMYT), Next Science (NXS), ICC Labs (ICC), Benchmark (BMK), ESSA Pharma (EPI) and Green Organic Dutchman (TGOD). View all competitors. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Canopy Growth (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), KushCo (KSHB), CannTrust (CTST), NVIDIA (NVDA), Green Organic Dutchman (TGOD) and Abattis Bioceuticals (ATT). Who are Aphria's key executives? Aphria's management team includes the following people: Mr. Carl A. Merton, Chief Financial OfficerMs. Megan McCrae, VP of MarketingMr. Irwin D. Simon, Interim CEO & ChairmanMr. Jakob Ripshtein, PresMr. Brett D. Marchand, Sr. VP of Operations What is Aphria's stock symbol? Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA." How do I buy shares of Aphria? Shares of APHA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Aphria's stock price today? One share of APHA stock can currently be purchased for approximately C$5.81. How big of a company is Aphria? Aphria has a market capitalization of C$1.55 billion and generates C$518.70 million in revenue each year. Aphria employs 300 workers across the globe. What is Aphria's official website? The official website for Aphria is www.aphria.com. How can I contact Aphria? Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
